NCT02502435

Brief Summary

This study wishes to look at the 24-hour rhythm of certain fats in the blood stream. Recent studies in animals and healthy participants suggest that unusual eating habits may be connected to a change in the 24-hour rhythm of the blood fats the investigators wish to measure. The investigators will ask persons suffering from night eating syndrome, a condition where people eat additional meals throughout the night, to participate in this study. Healthy volunteers who are of the same age and gender, and have a comparable body-mass-index, a number calculated from a person's weight and height, will also be asked to participate. The aim is to learn how the 24-hour rhythm of the blood fats the investigators measure differs between the persons experiencing the night eating episodes and persons who do not.

Trial Health

53
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial recruitment is currently suspended
Enrollment
12

participants targeted

Target at below P25 for all trials

Timeline
26mo left

Started Jul 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Jul 2015Jul 2028

Study Start

First participant enrolled

July 1, 2015

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

July 2, 2015

Completed
18 days until next milestone

First Posted

Study publicly available on registry

July 20, 2015

Completed
11.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2028

Last Updated

January 23, 2026

Status Verified

January 1, 2026

Enrollment Period

11.9 years

First QC Date

July 2, 2015

Last Update Submit

January 21, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Plasma fatty acids

    \[% total fatty acid pool\]

    64 hours

Secondary Outcomes (3)

  • Blood metabolite concentrations

    64 hours

  • Core body temperature

    64 hours

  • Bacterial taxa

    64 hours

Study Arms (2)

Patients with Night-Eating Syndrome

Individuals diagnosed with Night Eating Syndrome (NES); 18-65 years of age; eating 30% of their caloric intake after dinner with nocturnal awakenings to eat at a frequency of ≥ 5 times per week

Other: Observation

Matched Healthy Controls

Healthy volunteers; 18-65 years of age; eating \<25% of their caloric intake after dinner; no nocturnal ingestions

Other: Observation

Interventions

Observational study

Matched Healthy ControlsPatients with Night-Eating Syndrome

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with Night-Eating Syndrome: Participants have to meet both of the criteria for nocturnal ingestions and evening hyperphagia; eat 30% of their caloric intake after dinner with nocturnal wake ups to eat at a frequency of ≥ 5 times per week. Matching healthy participants: Participantswill be matched to a patient with Night-Eating Syndrome by gender, age and BMI.

You may qualify if:

  • Volunteers must be in good health as based on medical history, physical examination, vital signs, and laboratory tests as deemed by PI, BMI of 27-32;
  • Volunteers are capable of giving informed consent;
  • years of age;
  • Non-smoking; and
  • Non-pregnant, female subjects must consent to a urine pregnancy test.
  • Control subjects eat less than 25% of their caloric intake after dinner without nocturnal ingestions;
  • NES patients have to meet both of the criteria for nocturnal ingestions and evening hyperphagia; eat 30% of their caloric intake after dinner with nocturnal wake ups to eat at a frequency of ≥ 5 times per week

You may not qualify if:

  • Recent travel across time zones (within the past month);
  • Planned travel across time zones during the planned study activities;
  • Volunteers with irregular work hours, e.g. night shifts or swing shift schedule;
  • Subjects, who have received an experimental drug, used an experimental medical device within 30 days prior to screening, or who gave a blood donation of ≥ one pint within 8 weeks prior to screening;
  • Subjects with any abnormal laboratory value or physical finding that according to the investigator may interfere with interpretation of the study results, be indicative of an underlying disease state, or compromise the safety of a potential subject;
  • Diagnosis of severe depression, lifetime diagnosis of bipolar disorder or any psychotic disorder;
  • Prescription and non-prescription (OTC) medication; medication with psychotropics (including hypnotics);
  • Actively participating in a weight loss diet or program;
  • Diagnosed with a different eating disorder; and lack of awareness of the night eating episodes (to differentiate from nocturnal sleep-related eating disorder, in which nocturnal eating is accompanied by a lack of awareness at the time and amnesia for the behavior the following day.)
  • Subjects who have taken medications including antibiotics 2 weeks prior to the start of the study and throughout the study deemed by the investigator to interfere with the measurement of the study. Birth control pills are acceptable and will not be excluded;
  • Subjects who have taken aspirin or aspirin containing products for the 2 weeks prior to the start of the study and throughout the study;
  • Subjects who have taken acetaminophen, NSAIDS, COX-2 inhibitors (OTC or prescription) for 1 week prior to the start of the study and throughout the study;
  • Subjects who are currently consuming any type of tobacco product(s);
  • Use of recreational drugs within the last 6 months;
  • Subjects who consume high doses of antioxidant vitamins daily (vitamin C \> 1000mg, Vitamin E \> 400 IU, Beta Carotene \> 1000IU, Vitamin A \> 5000IU, Selenium \> 200mcg, Folic Acid \> 1mg) for the 2 weeks prior to the start of the study and throughout the study;
  • +12 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine

Philadelphia, Pennsylvania, 19104, United States

Location

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

Genetic analysis will be performed using High Throughput Sequencing (HTS) technology.

MeSH Terms

Conditions

Dyssomnias

Interventions

Observation

Condition Hierarchy (Ancestors)

Sleep Wake DisordersNervous System DiseasesMental Disorders

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Study Officials

  • Georgios Paschos, PhD

    University of Pennsylvania

    PRINCIPAL INVESTIGATOR
  • Kelly C Allison, PhD

    University of Pennsylvania

    PRINCIPAL INVESTIGATOR
  • Garret A FitzGerald, MD

    University of Pennsylvania

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant Professor

Study Record Dates

First Submitted

July 2, 2015

First Posted

July 20, 2015

Study Start

July 1, 2015

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

July 1, 2028

Last Updated

January 23, 2026

Record last verified: 2026-01

Locations